Announcements Trials
Browse Landscape

Phase

Phase 2 153Phase 1 97Phase 1/2 54Phase NA 31Phase 3 27Phase 4 5Phase 2/3 5Phase EARLY_PHASE1 2

Status

Completed 24Unknown 9Terminated 5Recruiting 4Not yet recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 29Genitourinary 23Thoracic 20Breast 19Other hematologic neoplasm 16Lymphoid 14Dermatologic 10Gynecologic 8Classical hematology 8Head & Neck 6Myeloid 5CNS 4Tumor-Agnostic 3Sarcoma 3Other 3Plasma cell 2Endocrine 2Other solid neoplasm 1Other neoplasm 1NET 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Polycythemia Vera 1Leukemia 1Chromosome Aberrations 1Bronchiolitis Obliterans Syndrome 1

Interventions

nilotinib 1bosutinib 1Imatinib Mesylate 1Hydroxyurea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Myeloid × Clear all
NCT05853458 2026-04-30

HU-F-AIM

Novartis

Phase 4 Terminated
76 enrolled
Myeloid

Polycythemia Vera

NCT02228382 2021-12-30

Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors

Pfizer

Phase 4 Terminated
163 enrolled 27 charts
MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02204722 2018-06-15

IDEAL

Dong-A ST Co., Ltd.

Phase 4 Terminated
55 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02086487 2017-03-07

NISRI

King Abdullah International Medical Research Center

Phase 4 Terminated
98 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00461929 2009-02-13

GIST

University Health Network, Toronto

Phase 4 Terminated
68 enrolled
MyeloidOther hematologic neoplasm

Chromosome Aberrations, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡